MDS Podcast Updates in Gene Therapy | Congress 2023
What gene therapies are the most promising the field of movement disorders? Dr. Sarah Camargos met with Prof. Deniz Kirk at the 2023 MDS Congress to get his perspective...
Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders.
Stay up to date on novel, clinically-relevant research findings in Parkinson’s disease and other movement disorders.
What gene therapies are the most promising the field of movement disorders? Dr. Sarah Camargos met with Prof. Deniz Kirk at the 2023 MDS Congress to get his perspective...
Dr. Sara Schaefer sits down with Prof. Carolyn Sue and Dr. Shilpa Chitnis to discuss the newest offerings in MDS Education; the MDS Career Development and LEAP Programs.
MDS President Francisco Cardoso shares with Dr. Sara Schaefer his important takeaways from his presidential term and his hopes for the future.
Basic science research for movement disorder therapies is booming. Prof. Tiago Outeiro asks Dr. Lorraine Kalia what therapeutic targets she thinks are stealing the stage at this year’s MDS...
The role of alpha-synuclein in various proteinopathies is still unknown. Prof. Poul Henning Jensen discusses this hot topic with Prof. Tiago Outeiro.
What new research is coming that may change the way clinicians treat tremor? Dr. Tiago Mestre shares his perspective on tremor treatment research with Dr. Hugo Morales.
What innovations in dystonia treatments do we have to look forward to? Dr. Mark Edwards sits down with Dr. Sarah Camargos to answer that vary question.
Why is Parkinson’s disease heterogeneity important to research. Dr. Connie Marras met with Dr. Eduardo Fernandez to discuss why understanding the heterogeneity of this disease may help with prevention.
How can sleep predict cognitive decline in Parkinson’s disease? Dr. Ron Postuma discusses his viewpoint and findings with Dr. Sarah Camargos at the MDS Congress.